If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Medical Affairs » Field Medical Excellence
Download FREE Excerpt
6 Info Graphics
22 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Pharmaceutical; Biopharmaceutical; Biotech; Consulting; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Communications; Clinical Research; Laboratories
Adamas Pharmaceuticals; Alkermes; Alnylam Pharmaceuticals; Amgen; Apellis Pharmaceuticals; Arcutis Biotherapeutics; ASC Therapeutics; Ashfield Healthcare; Astellas; AstraZeneca; Aurinia Pharmaceuticals; Baxter Healthcare; Bayer; BeiGene; BioMarin; Boehringer Ingelheim; Chiesi; Cipla; Clovis Oncology; Curis; Daiichi Sankyo; Dova Pharmaceuticals; Dr Reddy's Laboratories; Eisai; ERYTECH; Eurofarma; Foundation Medicine; GE Healthcare; Gilead Sciences; GlaxoSmithKline ; Greenwich Biosciences; Grifols; Grünenthal; Kartos Therapeutics; Kiniksa Pharmaceuticals; Kyowa Kirin; Legend Biotech; LEO Pharma; Merck; Mesoblast; Miravo Healthcare; NexGen Healthcare Communications; Novartis; Novo Nordisk; OM Pharma; Paratek Pharmaceuticals; Pfizer; Pharmacosmos Therapeutics Inc.; Radius Health; Inc.; Reata Pharmaceuticals; Sanofi; Sanofi Genzyme; Servier; Sunovion; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; Theravance; Travere Therapeutics; Urovant Sciences; Vertex Pharmaceuticals; Vifor Pharma; Zogenix
Best Practices, LLC engaged 100 Field Medical and Medical Affairs leaders from 62 biopharmaceutical companies through a benchmarking survey. More than half of research participants serve as Field Medical or Medical Affairs directors, while over 15% of participants serve at the executive level.
Key topics covered in this report include: